EMERDYNE Film-coated tablet Ref.[51194] Active ingredients: Escitalopram

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2021  Publisher: Macleods Pharmaceuticals SA (Pty) Ltd, Office Block 1, Bassonia Estate Office Park (East), 1 Cussonia Drive, Bassonia Rock, Ext. 12, Alberton, South Africa

Product name and form

EMERDYNE 10 mg (film-coated tablets).

EMERDYNE 20 mg (film-coated tablets).

Pharmaceutical Form

Film-coated tablet.

EMERDYNE 10 mg: A white to off white, circular, biconvex, film-coated tablet having “ML 60” debossed on one side, break line on opposite side and having notches on either ends of break line.

EMERDYNE 20 mg: A white to off white, circular, biconvex, film-coated tablet having “ML 61” debossed on one side, break line on opposite side and having notches on either ends of break line.

Qualitative and quantitative composition

Each film-coated tablet contains:

EMERDYNE 10 mg (film-coated tablets): Escitalopram oxalate corresponding to 10 mg escitalopram. Contains sugar. (104.33 mg of lactose monohydrate).

EMERDYNE 20 mg (film-coated tablets): Escitalopram oxalate corresponding to 20 mg escitalopram. Contains sugar. (208.67 mg of lactose monohydrate).

Excipients:

For a full list of excipients, see section 6.1.

Active Ingredient Description
Escitalopram

Escitalopram is a selective inhibitor of serotonin (5-HT) re-uptake with high affinity for the primary binding site. It also binds to an allosteric site on the serotonin transporter, with a 1000 fold lower affinity.

List of Excipients

Croscarmellose sodium
Isopropyl alcohol
Lactose monohydrate
Magnesium stearate
Propyl gallate
Sodium carboxymethylcellulose
Colloidal silicon dioxide
Hydroxypropylmethylcellulose
Titanium dioxide (E171)
Polyethylene glycol

Pack sizes and marketing

EMERDYNE 10 mg.

EMERDYNE 20 mg.

Blister pack:

Tablets are packed in cold form laminate, 25 ยตm OPA/45 ยตm Aluminum foil/60 ยตm PVC as the forming material and plain 25 micron, aluminum foil, 6-8 gsm HSL, as the lidding material.

Aluminium blister pack of 3 × 10 (30) tablets. The blisters are placed in an outer carton.

Marketing authorization holder

Macleods Pharmaceuticals SA (Pty) Ltd, Office Block 1, Bassonia Estate Office Park (East), 1 Cussonia Drive, Bassonia Rock, Ext. 12, Alberton, South Africa

Marketing authorization dates and numbers

EMERDYNE 10 mg: 45/1.2/0881
EMERDYNE 20 mg: 45/1.2/0882

10 October 2013

Drugs

Drug Countries
EMERDYNE South Africa

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.